SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000897069-20-000304
Filing Date
2020-07-10
Accepted
2020-07-09 17:32:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 cmw228.htm SC 13D 104855
3 image0.jpg GRAPHIC 13283
  Complete submission text file 0000897069-20-000304.txt   124868
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Subject) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90431 | Film No.: 201021215
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103 267-760-4066
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

IRS No.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D